Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with H...
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial
About this item
Full title
Author / Creator
von Minckwitz, Gunter, Prof , Puglisi, Fabio, MD , Cortes, Javier, MD , Vrdoljak, Eduard, Prof , Marschner, Norbert, MD , Zielinski, Christoph, Prof , Villanueva, Cristian, MD , Romieu, Gilles, MD , Lang, István, Prof , Ciruelos, Eva, MD , De Laurentiis, Michele, MD , Veyret, Corinne, Prof , de Ducla, Sabine, DEA , Freudensprung, Ulrich, MSc , Srock, Stefanie, MD and Gligorov, Joseph, MD
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Combining bevacizumab with first-line or second-line chemotherapy improves progression-free survival in HER2-negative locally recurrent or metastatic breast cancer. We assessed the efficacy and safety of further bevacizumab therapy in patients with locally recurrent or metastatic breast cancer whose disease had progressed after t...
Alternative Titles
Full title
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial
Authors, Artists and Contributors
Author / Creator
Puglisi, Fabio, MD
Cortes, Javier, MD
Vrdoljak, Eduard, Prof
Marschner, Norbert, MD
Zielinski, Christoph, Prof
Villanueva, Cristian, MD
Romieu, Gilles, MD
Lang, István, Prof
Ciruelos, Eva, MD
De Laurentiis, Michele, MD
Veyret, Corinne, Prof
de Ducla, Sabine, DEA
Freudensprung, Ulrich, MSc
Srock, Stefanie, MD
Gligorov, Joseph, MD
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1751228383
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751228383
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(14)70439-5